TOI
Oncology Institute Inc
6.20$
+20.9%
vs. previous close
Closing price · As of: Aug 11, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 45.3% | 69.9% | 68.6% | 69.0% | 64.7% | 65.0% | 65.1% | 65.1% | 65.6% | 67.3% | 68.5% | 69.5% | |
| 12.6% | 12.6% | 16.0% | 17.6% | 20.3% | 26.5% | 28.8% | 24.2% | 19.0% | 16.9% | 20.4% | 18.0% | |
| 17.0% | 40.0% | 39.6% | 32.2% | 25.8% | 26.5% | 28.8% | 24.2% | 19.0% | 16.9% | 20.4% | 18.0% | |
| 20.4% | 22.4% | 20.5% | 28.9% | 30.3% | 30.6% | 28.2% | 30.3% | 34.8% | 36.7% | 36.0% | 35.3% | |
| 5.3% | 5.6% | 6.5% | 5.6% | 6.3% | 5.6% | 5.8% | 7.5% | 9.9% | 11.5% | 10.2% | 14.4% | |
| 4.7% | – | – | – | – | – | – | – | – | – | – | – | |
| 3.1% | 3.3% | 3.5% | 3.5% | 4.0% | 4.0% | 4.2% | 4.4% | 4.5% | 4.4% | 4.4% | 4.3% | |
| 8.4% | 8.5% | 8.6% | 8.4% | 9.1% | 8.7% | 8.6% | 8.6% | 7.8% | 7.2% | 6.7% | 6.1% | |
| 63.2% | 67.1% | 72.7% | 79.8% | 83.7% | 91.4% | 97.9% | 96.9% | 105.6% | 107.5% | 109.5% | 109.7% | |
| 14.6% | 14.8% | 16.6% | 22.4% | 19.5% | 26.1% | 30.2% | 36.3% | 40.5% | 40.1% | 43.1% | 47.2% | |
| 2.6% | 2.8% | 3.0% | 3.1% | 7.3% | 3.8% | 3.9% | 4.2% | 4.6% | 4.4% | 4.3% | 4.4% | |
| 5.7% | 6.1% | 6.9% | 10.3% | 8.8% | 13.7% | 14.1% | 17.9% | 21.9% | 21.8% | 26.2% | 28.3% | |
| 36.4% | 39.0% | 41.5% | 43.2% | 50.1% | 51.1% | 53.9% | 45.1% | 46.9% | 46.6% | 47.0% | 46.7% | |
| 36.8% | 32.9% | 27.3% | 20.2% | 16.3% | 8.6% | 2.1% | 3.1% | -5.6% | -7.5% | -9.5% | -9.7% | |
| -47.8% | -58.3% | -69.8% | -81.2% | -101.1% | -110.3% | -122.1% | -140.5% | -154.8% | -161.3% | -164.8% | -162.8% | |
| 32.2% | 33.6% | 35.1% | 36.3% | 41.6% | 42.1% | 43.8% | 47.0% | 583.3% | 595.7% | 616.2% | 605.1% |
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.